The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

ComboPen     [(E)-(1-methylpyridin-2- ylidene)methyl]...

Synonyms: Protopam, Duodote, pralidoxime, Pralidoximum, CHEMBL1420, ...
This record was replaced with 5353895.
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of (2E)-1-methyl-2-(nitrosomethylidene)pyridine


Psychiatry related information on (2E)-1-methyl-2-(nitrosomethylidene)pyridine


High impact information on (2E)-1-methyl-2-(nitrosomethylidene)pyridine


Chemical compound and disease context of (2E)-1-methyl-2-(nitrosomethylidene)pyridine


Biological context of (2E)-1-methyl-2-(nitrosomethylidene)pyridine


Anatomical context of (2E)-1-methyl-2-(nitrosomethylidene)pyridine


Associations of (2E)-1-methyl-2-(nitrosomethylidene)pyridine with other chemical compounds


Gene context of (2E)-1-methyl-2-(nitrosomethylidene)pyridine


Analytical, diagnostic and therapeutic context of (2E)-1-methyl-2-(nitrosomethylidene)pyridine


  1. Nerve agents: a review. Gunderson, C.H., Lehmann, C.R., Sidell, F.R., Jabbari, B. Neurology (1992) [Pubmed]
  2. O-Substituted derivatives of pralidoxime: muscarinic properties and protection against soman effects in rats. Loke, W.K., Sim, M.K., Go, M.L. Eur. J. Pharmacol. (2002) [Pubmed]
  3. Receptor-mediated presynaptic facilitation of quantal release of acetylcholine induced by pralidoxime in Aplysia. Fossier, P., Baux, G., Poulain, B., Tauc, L. Cell. Mol. Neurobiol. (1990) [Pubmed]
  4. Severe fenthion intoxications due to ingestion and inhalation with survival outcome. Tsatsakis, A.M., Bertsias, G.K., Liakou, V., Mammas, I.N., Stiakakis, I., Tzanakakis, G.N. Human & experimental toxicology. (2002) [Pubmed]
  5. Respiratory failure from severe organophosphate toxicity due to absorption through the skin. Peiris, J.B., Fernando, R., De Abrew, K. Forensic Sci. Int. (1988) [Pubmed]
  6. Acute soman poisoning in primates neither pretreated nor receiving immediate therapy: value of gacyclidine (GK-11) in delayed medical support. Lallement, G., Clarençon, D., Galonnier, M., Baubichon, D., Burckhart, M.F., Peoc'h, M. Arch. Toxicol. (1999) [Pubmed]
  7. The neurobehavioral effects of pralidoxime mesylate in the rat. Liu, W.F., Beaton, J.M. Neurobehavioral toxicology and teratology. (1985) [Pubmed]
  8. Effect of intravenous thiamine on pralidoxime kinetics. Josselson, J., Sidell, F.R. Clin. Pharmacol. Ther. (1978) [Pubmed]
  9. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Worek, F., Thiermann, H., Szinicz, L., Eyer, P. Biochem. Pharmacol. (2004) [Pubmed]
  10. Potential use of autoinjector-packaged antidotes for treatment of pediatric nerve agent toxicity. Henretig, F.M., Mechem, C., Jew, R. Annals of emergency medicine. (2002) [Pubmed]
  11. Pharmacological profile of CEB-1957 and atropine toward brain muscarinic receptors and comparative study of their efficacy against sarin poisoning. Trovero, F., Brochet, D., Breton, P., Tambuté, A., Bégos, A., Bizot, J.C. Toxicol. Appl. Pharmacol. (1998) [Pubmed]
  12. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. Kassa, J. J. Toxicol. Clin. Toxicol. (2002) [Pubmed]
  13. Acetylcholinesterase inhibition: does it explain the toxicity of organophosphorus compounds? Maxwell, D.M., Brecht, K.M., Koplovitz, I., Sweeney, R.E. Arch. Toxicol. (2006) [Pubmed]
  14. Management of acute childhood poisonings caused by selected insecticides and herbicides. Mortensen, M.L. Pediatr. Clin. North Am. (1986) [Pubmed]
  15. Chlorpyrifos-induced delayed polyneuropathy. Capodicasa, E., Scapellato, M.L., Moretto, A., Caroldi, S., Lotti, M. Arch. Toxicol. (1991) [Pubmed]
  16. Improvement of motor function in multiple sclerosis by use of protopam chloride. Cook, A.W., Nidzgorski, F., Oygar, A. Acupuncture & electro-therapeutics research. (1992) [Pubmed]
  17. Pralidoxime mesylate absorption and heart rate response to atropine sulphate following intramuscular administration of solution mixtures. Holland, P., Parkes, D.C., White, R.G. British journal of clinical pharmacology. (1975) [Pubmed]
  18. Effects of soman and its antidotes on tracheal mucociliary transport of ferrets. Marin, M.G., Zwierzynski, D., McBride, R.K., Culp, D.J. J. Appl. Physiol. (1989) [Pubmed]
  19. The pharmacokinetics of continuous infusion pralidoxime in children with organophosphate poisoning. Schexnayder, S., James, L.P., Kearns, G.L., Farrar, H.C. J. Toxicol. Clin. Toxicol. (1998) [Pubmed]
  20. Effect of some cationic drugs on the intestinal absorption of pralidoxime iodide. Suzuki, E., Doi, K., Kondo, T., Matsui, H., Sezaki, H. Chem. Pharm. Bull. (1975) [Pubmed]
  21. Hydrolysis of an acetylthiocholine by pralidoxime iodide (2-PAM). Sakurada, K., Ikegaya, H., Ohta, H., Akutsu, T., Takatori, T. Toxicol. Lett. (2006) [Pubmed]
  22. Concentrations of 2-hydroxyiminomethyl-N-methylpyridinium ion in plasma and aqueous humor as indices of the toxicity of pralidoxime mesylate (P2S) for the rabbit. Ballantyne, B., Gazzard, M.F., Robson, D.C., Swanston, D.W. Toxicol. Appl. Pharmacol. (1975) [Pubmed]
  23. Protective effect of early and late administration of pralidoxime against organophosphate muscle necrosis. Santos, R.P., Cavaliere, M.J., Puga, F.R., Narciso, E.S., Pelegrino, J.R., Calore, E.E. Ecotoxicol. Environ. Saf. (2002) [Pubmed]
  24. Pralidoxime iodide (2-pAM) penetrates across the blood-brain barrier. Sakurada, K., Matsubara, K., Shimizu, K., Shiono, H., Seto, Y., Tsuge, K., Yoshino, M., Sakai, I., Mukoyama, H., Takatori, T. Neurochem. Res. (2003) [Pubmed]
  25. Drug uptake into everted intestinal sacs. II. Inhibition of secretion by hypertonicity. Hurwitz, A. Am. J. Physiol. (1979) [Pubmed]
  26. Effects of pralidoxime applied locally into the midbrain reticular formation on the hippocampal theta rhythm induced by acetylcholinesterase inhibition. Kowalczyk, M. Acta physiologica Polonica. (1988) [Pubmed]
  27. Pralidoxime chloride stability-indicating assay and analysis of solution samples stored at room temperature for ten years. Schroeder, A.C., DiGiovanni, J.H., Von Bredow, J., Heiffer, M.H. Journal of pharmaceutical sciences. (1989) [Pubmed]
  28. Urinary excretion of diethylphosphorus metabolites in persons poisoned by quinalphos or chlorpyrifos. Vasilić, Z., Drevenkar, V., Rumenjak, V., Stengl, B., Fröbe, Z. Arch. Environ. Contam. Toxicol. (1992) [Pubmed]
  29. Nerve agent poisoning in primates: antilethal, anti-epileptic and neuroprotective effects of GK-11. Lallement, G., Clarençon, D., Masqueliez, C., Baubichon, D., Galonnier, M., Burckhart, M.F., Peoc'h, M., Mestries, J.C. Arch. Toxicol. (1998) [Pubmed]
  30. Plasma concentrations of pralidoxime methylsulphate in organophosphorus poisoned patients. Willems, J.L., Langenberg, J.P., Verstraete, A.G., De Loose, M., Vanhaesebroeck, B., Goethals, G., Belpaire, F.M., Buylaert, W.A., Vogelaers, D., Colardyn, F. Arch. Toxicol. (1992) [Pubmed]
  31. A comparison of trimedoxime, obidoxime, pralidoxime and HI-6 in the treatment of oral organophosphorus insecticide poisoning in the rat. Jokanović, M., Maksimović, M. Arch. Toxicol. (1995) [Pubmed]
  32. Ligand stabilization of cholinesterases. Payne, C.S., Saeed, M., Wolfe, A.D. Biochim. Biophys. Acta (1989) [Pubmed]
  33. Neuroparalysis and oxime efficacy in organophosphate poisoning: a study of butyrylcholinesterase. Khan, S., Hemalatha, R., Jeyaseelan, L., Oommen, A., Zachariah, A. Human & experimental toxicology. (2001) [Pubmed]
  34. Efficacy of an adenosine A1 receptor agonist compared with atropine and pralidoxime in a rat model of organophosphate poisoning. Kalkan, S., Ergur, B.U., Akgun, A., Kaplan, Y.C., Kinay, A.O., Tuncok, Y. Human & experimental toxicology. (2005) [Pubmed]
  35. Human leukocyte migration inhibitory factor (LIF) III. Further investigations on the serine protease nature of this lymphokine and its preference for arginine amides. Bendtzen, K. Scand. J. Immunol. (1977) [Pubmed]
  36. Analysis of formulations containing pralidoxime mesylate by liquid chromatography. Utley, D. J. Chromatogr. (1987) [Pubmed]
  37. High-performance liquid chromatographic determination of pralidoxime chloride and its major decomposition products in injectable solutions. Prue, D.G., Johnson, R.N., Kho, B.T. Journal of pharmaceutical sciences. (1983) [Pubmed]
  38. Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. Eddleston, M., Szinicz, L., Eyer, P., Buckley, N. QJM : monthly journal of the Association of Physicians. (2002) [Pubmed]
  39. Neuroleptic malignant-like syndrome: a complication of acute organophosphate poisoning. Ochi, G., Watanabe, K., Tokuoka, H., Hatakenaka, S., Arai, T. Canadian journal of anaesthesia = Journal canadien d'anesthésie. (1995) [Pubmed]
WikiGenes - Universities